全膝关节置换术中延长抗生素使用与假体周围关节感染率降低无关
该回顾性队列研究基于2000至2018年17,223例全膝关节置换术的注册数据,按预防性抗生素使用时长分为标准疗程(≤24小时)组15,160例(88.0%)和延长疗程(>24小时)组2,063例(12.0%)。结果显示假体周围关节感染(PJI)总发生率为0.39%(68例),标准组0.40%(61例)与延长组0.34%(7例)相比无显著差异(P=0.67),高危患者延长抗生素也未降低PJI率,两组2年随访结局评分和满意度无差异。
要点
- 标准疗程组PJI发生率0.40%(61例)与延长疗程组0.34%(7例)相比无显著差异(P=0.67)。
- 高危患者(Charlson合并症指数>2、糖尿病、慢性肾脏病、肥胖)使用延长疗程抗生素未显示PJI率降低。
- 两组2年随访的牛津膝关节评分、Short Form-36及满意度评分均无差异。
核心结论
- 在全膝关节置换术中,延长预防性抗生素使用与标准和 broom 高危患者2年时PJI率降低均无关。
- 作者认为应反对在全膝关节置换术中常规使用延长疗程抗生素。
- 作者认为某些高危患者群体可能仍从延长疗程抗生素中获益,未来研究应聚焦于识别这些患者。
研究设计与样本
- 回顾性队列研究(证据等级III级),审查2000年至2018年间实施的17,223例全膝关节置换术的注册数据。
- 按接受标准疗程(≤24小时)或延长疗程(>24小时)抗生素分组,记录两组需再次手术的PJI发生率。
- 在术前、6个月和2年随访时使用牛津膝关节评分、Short Form-36和术后满意度进行临床评估。
- 17,223例患者中,15,160例(88.0%)接受标准疗程抗生素,2,063例(12.0%)接受延长疗程抗生素。
主要发现
- 共识别68例(0.39%)PJI病例:标准疗程组61例(0.40%),延长疗程组7例(0.34%),P=0.67。
- 高危患者(如Charlson合并症指数>2、糖尿病、慢性肾脏病、肥胖)接受延长疗程抗生素未显示PJI率降低。
- 两组在2年时结局测量指标或满意度评分均无差异。
临床怎么用
- 作者认为应反对在全膝关节置换术中常规使用延长疗程抗生素。
- 作者认为某些高危患者群体可能仍从延长疗程抗生素中获益,未来研究应聚焦于识别这些患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prophylactic antibiotics are essential in preventing periprosthetic joint infection (PJI) in total knee arthroplasty (TKA), but the optimal duration of administration remains controversial. Existing studies lack long-term follow-up, suffer from small sample sizes, and are limited by cohort heterogeneity. This study aimed to determine whether the duration of prophylactic antibiotics affects PJI rates in TKA. METHODS: Registry data of 17,223 TKAs performed between 2000 and 2018 were reviewed. Patients were grouped by receiving standard (≤ 24 hours) or extended (> 24 hours) antibiotics. The prevalence of PJI requiring reoperation was recorded for both groups, with clinical assessment at preoperative, 6-month, and 2-year follow-up using the Oxford Knee Score, Short Form-36, and postoperative satisfaction. Of the 17,223 patients, 15,160 (88.0%) received standard-course antibiotics, and 2,063 (12.0%) received extended-course antibiotics. RESULTS: A total of 68 (0.39%) PJI cases were identified: 61 in the standard group (0.40%) and seven in the extended group (0.34%, P = 0.67). High-risk patients (e.g., Charlson Comorbidity Index > 2, diabetes, chronic kidney disease, obesity) on extended-course antibiotics did not show a reduced PJI rate. No differences in outcome measures or satisfaction scores were noted at two years. CONCLUSIONS: Extended antibiotic prophylaxis in TKA was not associated with reduced PJI rates in both normal and high-risk patients at two years. The routine use of extended-course antibiotics in TKA should be discouraged. Certain high-risk patient groups may still benefit from extended-course antibiotics, and future studies should focus on identifying them. LEVEL OF EVIDENCE: Level III, Retrospective Cohort Study.
引用
- Tay AYW, Liow LMH, Pang HN, et al. Extended Antibiotic Use in Total Knee Arthroplasty Is Not Associated With Decreased Periprosthetic Joint Infection Rates. J Arthroplasty. 2025. PMID: 41101565. doi:10.1016/j.arth.2025.10.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。